Presentation Information

[P2-78]AI-Guided Rational Design of Next-Generation Dengue Fever Vaccine

*Sebastian Kapell2,1, Shara Bakytbek4,9, Farzaneh Valanezhad4,9, Mya Myat Ngwe Tun9,10, Jean Claude Balingit10, Ayako Hyuga4,9, Shin-Ichi Inoue9,6, Yui Katsuyuki9,6, Shusaku Mizukami5,9, Shinjiro Hamano4,9, Matheus Ferraz2, Ioannis Vardaxis2, Daiki Mori3, Daiki Miura3, Kazuhide Onoguchi3, Kaidre Bendjama2,1, Basu Dev Pandey8, Corazon Cerilla Buerano10, Trevor Clancy2, Haruka Abe9,11, Satoshi Kaneko9,7, Kouichi Morita10,9 (1. Department of Vaccine Informatics, Institute of Tropical Medicine, Nagasaki University (Japan), 2. NEC Oncoimmunity AS (Norway), 3. NEC Corporation (Japan), 4. Department of Parasitology, Institute of Tropical Medicine, Nagasaki University (Japan), 5. Department of Immune Regulation, SHIONOGI global infectious diseases division (SHINE), Institute of Tropical Medicine (NEKKEN), Nagasaki University (Japan), 6. Department of Immunology, Graduate School of Biomedicine, Nagasaki University (Japan), 7. Department of Eco-Epidemiology, Institute of Tropical Medicine, Nagasaki University (Japan), 8. Department of Molecular Epidemiology, Institute of Tropical Medicine, Nagasaki University (Japan), 9. Vaccine Research and Development Center Infectious Disease Research Alliance (DEJIMA), Nagasaki University (Japan), 10. Department of Tropical Viral Vaccine Development, Institute of Tropical Medicine, Nagasaki University (Japan), 11. Vietnam Research Station, NEKKEN, Nagasaki University (Japan))

Password required to view


Comment

To browse or post comments, you must log in.Log in